Exelixis, Inc.
(NASDAQ:
EXEL) shares jumped 47.57 percent to $5.77 after the company reported positive top-line results from METEOR, Phase 3 pivotal trial of Cabozantinib vs. Everolimus in patients with metastatic renal cell carcinoma.
Vivint Solar Inc (NYSE:
VSLR) shares climbed 43.89 percent to $15.67 after the company agreed to be acquired by
Sunedison Inc (NASDAQ:
SUNE) for $2.2 billion.
Lennox International Inc. (NYSE:
LII) shares surged 9.50 percent to $117.81 on better-than-expected Q2 earnings.
Hasbro, Inc. (NASDAQ:
HAS) gained 5.66 percent to $82.68 after the company reported upbeat Q2 results.
Horizon Pharma PLC (NASDAQ:
HZNP) rose 5.23 percent to $39.02 after the company issued a strong Q2 sales forecast.
Halliburton Company (NYSE:
HAL) shares surged 3.19 percent to $41.28 after the company reported stronger-than-expected results for its second quarter.
Cellectis SA (ADR) (NASDAQ:
CLLS) shares gained 3.07 percent to $41.00. Bank of America initiated coverage on Cellectis with a Buy rating and a $50.00 price target.
Morgan Stanley (NYSE:
MS) shares rose 1.65 percent to $40.90 after the company reported upbeat earnings for the second quarter.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
